USNA
USANA Health Sciences Inc
14.00$
-5.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.5% | 57.7% | 59.0% | 65.5% | 70.8% | 63.4% | 66.0% | 62.8% | 63.9% | 66.0% | 37.3% | 38.8% | |
| 31.7% | 33.8% | 37.3% | 47.6% | 38.7% | 45.4% | 48.8% | 41.5% | 48.3% | 52.2% | 24.3% | 21.3% | |
| 31.7% | 33.8% | 37.3% | 47.6% | 50.1% | 45.4% | 48.8% | 41.5% | 48.3% | 52.2% | 24.3% | 21.3% | |
| 3.7% | 2.8% | 3.6% | 2.6% | 2.5% | 1.7% | 1.2% | 1.2% | 1.2% | 1.1% | 1.1% | – | |
| 12.9% | 15.6% | 13.8% | 12.1% | 14.8% | 13.3% | 14.1% | 17.0% | 11.2% | 9.7% | 9.3% | 13.8% | |
| 20.3% | 20.8% | 21.5% | 19.8% | 16.6% | 18.4% | 15.7% | 17.6% | 18.7% | – | – | – | |
| 5.1% | 4.1% | 3.6% | 3.4% | 3.0% | 3.2% | 2.7% | 3.1% | 2.9% | 2.7% | 19.3% | 18.6% | |
| 11.7% | 9.0% | 7.3% | 6.8% | 5.7% | 5.8% | 4.8% | 5.3% | 5.4% | 4.7% | 20.3% | 17.9% | |
| 34.3% | 33.6% | 30.9% | 30.1% | 29.5% | 32.0% | 31.1% | 31.6% | 27.2% | 21.4% | 21.6% | 21.1% | |
| 31.0% | 31.0% | 29.4% | 27.2% | 26.8% | 26.3% | 26.2% | 27.8% | 24.1% | 18.8% | 18.7% | 17.3% | |
| 4.5% | 4.2% | 4.6% | 3.3% | 3.7% | 1.6% | 1.3% | 1.2% | 1.2% | 1.3% | 3.9% | 1.9% | |
| 2.2% | 2.4% | 1.9% | 2.3% | 1.8% | 2.4% | 2.8% | 2.3% | 1.9% | 1.6% | 1.6% | 2.3% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 65.7% | 66.4% | 69.1% | 69.9% | 70.5% | 68.0% | 68.9% | 68.4% | 72.8% | 78.6% | 71.1% | 71.8% | |
| 47.5% | 50.8% | 56.4% | 55.5% | 59.4% | 59.2% | 59.7% | 59.7% | 65.7% | 70.4% | 64.0% | 62.7% | |
| 7.8% | 6.2% | 5.3% | 4.8% | 4.4% | 4.4% | 3.3% | 3.5% | 3.2% | 3.1% | 2.6% | 2.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.